Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
Time for a Digital Revolution in the Women’s Health Market
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
save 25 %
* Required Fields
Pay by invoice
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such as high cost of next-generation sequencing (NGS), reimbursement scenario and the establishment of clinical utility of mutation and clinical evidence.Liquid biopsy remains an interesting business opportunity for several investors and the quest for the most successful company continues. With GRAIL announcing over $1.3 billion in financing, the modality has also garnered interest from several pharma companies vying to capture their share of the market by co-developing drugs and diagnostic products. CTCs and ctDNAs have extended applications across oncology, NIPT (non-invasive prenatal testing), transplant diagnostics and infectious diseases. This report provides a strategic insight into liquid biopsy test makers relating to the challenges they will encounter and lists some of the winning strategies to gain reimbursement and market access. It also highlights growth opportunities where companies can gain the first-mover advantage, and provides a guidance for investment bankers on the most successful and unique disruptive technology.It is important to identify winning strategies in order to be successful. Given the tricky nature of this market, establishing clinical utility and clinical evidence and getting the test into guidelines are some of the key pathways for success. This report discusses regional challenges, regulatory barriers in the UK, China and the US. Key drivers would include the following: Identifying the area of unmet need; aiming for incorporating the test within guidelines and screening programs; overcoming regulatory and reimbursement barriers; and innovating to draw maximum capital from investors.Broadly three types of companies form the competitive landscape in this market - liquid biopsy kit providers, liquid biopsy instrument providers. Most activity is sensed within “liquid biopsy as a service model”.Currently, there are no clear guidelines that provide a definitive regulatory/ reimbursement roadmap in emerging countries such as India where the concept is still in its nascent stages.Top market trends include: • Increasing interest from pharma companies forging partnerships with diagnostic test developers to advance their drug discovery and development activities.• Companies are leaning towards biomarkers that are listed in the NCCN guidelines as a low-risk approach and which offer more guaranteed reimbursement. • Biomarker tests are focusing on multi-gene or multi-cancer testing rather than a single gene approach. • Companies are pushing the boundaries beyond oncology testing.
INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, ADVANCED DIAGNOSTICS, AND DIGITAL THERAPY PLATFORMS
GROWTH OPPORTUNITIES IN TARGETED CANCER THERAPY & CANCER DIAGNOSTICS, VIRAL VECTORS, MULTIPLE DISEASES, RETINAL DISEASES, AND COSMECEUTICALS
Transformational Growth Powering the Digital Operating Room Market in the United States and Western Europe
INNOVATIONS AND GROWTH OPPORTUNITIES IN NEUROSTIMULATION DEVICES, POINT-OF CARE DIAGNOSTICS, AND NOVEL IMPLANT PLATFORMS
Artificial Intelligence Powering the Global Medical Imaging Market
GROWTH OPPORTUNITIES IN GENE THERAPIES, CANCER, DISEASE TREATMENT & MONITORING, SURGICAL APPLICATIONS AND COSMETICS
Innovations and Growth Opportunities in Surgical Robots, Mental Health Therapeutic Devices and Novel Diagnostic and Monitoring Devices
COVID-19 Pandemic and Rising Prevalence of Respiratory Disorders Catapult Growth in Global Extracorporeal Membrane Oxygenation (ECMO) Market
Emerging Neuromodulation Technologies Enabling Growth Opportunities in Mental Health Care
GROWTH OPPORTUNITIES IN GENE THERAPIES FOR RARE GENETIC DISORDERS, DRUG DELIVERY THERAPIES, ANTIBIOTICS, AND COVID-19 VACCINES
consumer drone market
solar energy market
glucose monitoring devices market
nanophotonic equipment market
heavy commercial vehicles market
composite materials market
medical supplies market
virtual reality market
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.